GlassScriptPhysician profile
Chohee Park
NPI 1881312924
$4,968.21
in general payments reported to CMS, 2019-2025
19 companies · $2,515 in 2025
The $2,515 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $431 · 2024: $2,022 · 2025: $2,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,771 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,771.09 |
| Education | $197.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,059.80 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $745.08 | 2024-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $531.52 | 2024-2025 | Adbry |
| Pfizer INC. | $385.34 | 2023-2025 | |
| Janssen Biotech, INC. | $331.76 | 2023-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $307.20 | 2024-2025 | |
| Incyte Corporation | $287.59 | 2024-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $233.66 | 2024-2025 | Sotyktu |
| Lilly USA, LLC | $229.02 | 2024-2025 | Ebglyss, Taltz |
| Novartis Pharmaceuticals Corporation | $155.81 | 2025 | |
| Ucb, INC. | $151.45 | 2024-2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $120.84 | 2024-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $103.60 | 2023-2025 | Siliq, Jublia, Cabtreo |
| Galderma Laboratories, L.P. | $103.00 | 2025 | Nemluvio |
| Amgen INC. | $75.36 | 2023-2024 | Otezla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $53.36 | 2025 | Sofdra |
| Genzyme Corporation | $48.81 | 2023-2024 | |
| Convatec INC. | $26.43 | 2025 | |
| Kyowa Kirin, INC. | $18.58 | 2024 | Poteligeo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chohee Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.